Imaging Wire #200
“Thanks to the helpers. Let’s take care of ourselves and each other.” Tom Hanks from quarantine this weekend. Happy 200th Imaging Wire issue, everyone. It doesn’t…
US-Guided Breakthrough | No Patients on the EHR | No Non-Radiologists
“This technology is essentially producing the world’s most advanced selfie, and the benefit is that there’s nothing dangerous about it.” Hospital for Special Surgery’s Howard J.…
Topol’s Doctors Union | Exo’s Big Goals | Mednax Steps Back
“Why not? Why aren’t doctors standing up for themselves and their patients?” Eric Topol questioning why doctors aren’t organizing and taking a stand against the problems…
Mid-Level Attack | AI Hype | Siemens Gets Flexible
“. . . companies that people assume and think are AI companies are probably not.” MMC researcher, David Kelnar, after finding that 40% of European AI…
Big AI Investments | Specialist Faceoff | AI’s Med Student Impact
“This is not peanuts.” Philips CEO, Frans van Houten, on the $69 million profit hit the company is expecting in 2019 as a result of the…
Human Consciousness Imaging
“We may for the first time capture a full picture of human consciousness or even the essence of life itself.” An unnamed physicist involved in China’s…
AI Alzheimer’s Detector | AI’s Multi-System Problem | Pipe Organ Ultrasound
“Musical instruments have a wide variety of designs but they all have one thing in common – they emit sound across a broad range of frequencies.…
Trimodal Platform | Radiation Deregulation | Lung CT Evidence
“Our nanoplatform is designed to enable multimodal molecular imaging, thus overcoming the intrinsic limitations of each single image modality while maximizing their advantages.” Complutense University of…
The Case for CPUs | IAMERS’ Evidence | The MRI Market
“This is a win-win for both the patient and the physician—it is taking advantage of modern healthcare technology at no additional cost to the patient.” Kansas…
Spine Partnership | Coil Breakthrough | Mood Disorder fMRI AI
“This study takes a major step towards finding a biomarker of medication response in emerging adults with complex mood disorders. . . It also suggests that…
